CCX-624

N/A

Report date: 2025/01/26 19:30:31
NME

Base Information

Drug NameCCX-624
Drug Alias NameCCR6/CXCR2 antagonist (ChemoCentryx)CCX-624
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 2 antagonistsC-C chemokine receptor type 6 inhibitors
TargetsC-C chemokine receptor type 6C-X-C motif chemokine receptor 2
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChemocentryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen Inc
Inactive CompaniesChemocentryx Inc
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A